Inflammatory breast carcinoma: Pathological or clinical entity?

Breast Cancer Research and Treatment

Volumn 64, Issue 3, 2000, Pages 269-273

  Amparo, R S ^a   Angel, C D M ^a   Ana, L H ^b   Antonio, L C ^a   Vicente, M S ^a   Carlos, F M ^a   Vicente, G P ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Clinical or pathological diagnosis; Inflammatory breast carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER SURVIVAL; FEMALE; HUMAN; INFLAMMATORY DISEASE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0034531093     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026512722789     Document Type: Article

References (21)

1. Inflammatory carcinoma of the breast
2. Inflammatory carcinoma of the breast
3. Inflammatory carcinoma of the breast. A pathologic definition
4. Clinically occult inflammatory carcinoma of the breast
5. Inflammatory carcinoma of the breast: A correlation of clinical, radiologic and pathologic findings
6. Management of inflammatory breast carcinoma
7. Prognostic factors in inflammatory breast cancer and therapeutic implications
8. Protocole schematique de traitement des cancers du sein en phase evolutive
9. Inflammatory carcinoma of the breast
10. Inflammatory breast cancer: The experience of the surveillance, epidemiology, and end results (SEER) Program
11. Inflammatory cancer of the breast: Analysis of 114 cases
12. Inflammatory breast carcinoma treated by radical radiotherapy
13. Acute mammary carcinoma
14. Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia
15. Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy
16. Inflammatory carcinoma of the breast
17. Management of inflammatory carcinoma of the breast. A combined modality approach
18. Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast
19. Estrogen receptor status in inflammatory breast carcinoma
20. Management of locally advanced carcinoma of the breast. Inflammatory carcinoma
21. Inflammatory breast carcinoma. An effective multimodal approach